A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma
2008 · Respiratory Medicine · 44 citations
https://doi.org/10.1016/j.rmed.2008.06.017
P
Petter Olsson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
87
Papers
1.7K
Citations
23
h-index
33
i10-index
Petter Olsson is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Asthma and respiratory diseases & Chronic Obstructive Pulmonary Disease (COPD) Research & Allergic Rhinitis and Sensitization. The author has an h-index of 23, co-authored 74 publications.
ORCID: 0000-0002-3913-3914Papers by this author
worksHealthSWEDE: costs with sublingual immunotherapy—a Swedish questionnaire study
2021 · Allergy Asthma and Clinical Immunology · 4 citations
https://doi.org/10.1186/s13223-021-00560-3
Additional file 1: of Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.5691691
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat